Electric Therapy Traction Table Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
The global Peptide CDMO market was valued at US$ 3265.7 million in 2022 and is projected to reach US$ 8327.1 million by 2029, at a CAGR of 14.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global key peptide CDMO producers include Bachem, PolyPeptide, CordenPharma, and others. The top five manufacturers together account for 40% of the market share, with the largest manufacturer being Bachem with 17%. At the sales level, North America is the largest sales market with a market share of over 50%, followed by Europe and China with 33% and 9% respectively. In terms of product categories, it is divided into APIs and intermediates and FDF, with the former holding the major market share of 67%. In terms of application, commercial is the top application area with a market share of 76%, followed by academic research institutions.
Peptides are synthesized by coupling the carboxyl group of one amino acid to the amino group of another amino acid molecule. Due to the possibility of unintended reactions, protecting groups are common necessary. Chemical peptide synthesis most commonly starts at the carboxyl end of the peptide, and thus progress toward the amino-terminus. This is the opposite direction of protein biosynthesis.
A contract development and manufacturing company (CDMO) is a company within the pharmaceutical industry that provides drug development and manufacturing services. Pharmaceutical companies partner with CDMOs as a way to outsource drug development and drug manufacturing.
CDMO peptides production via contract peptide manufacturing is to optimize process development and achieve highly efficient conversion at every amino acid coupling to produce a high-purity crude synthetic custom peptide and minimize the demands on downstream processing.
This report aims to provide a comprehensive presentation of the global market for Peptide CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide CDMO. This report contains market size and forecasts of Peptide CDMO in global, including the following market information:
Global Peptide CDMO Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Peptide CDMO companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peptide CDMO Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Peptide CDMO Market Segment Percentages, by Type, 2022 (%)
APIs and Intermediates
FDF
Global Peptide CDMO Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Peptide CDMO Market Segment Percentages, by Application, 2022 (%)
Commercial
Academic Research
Other
Global Peptide CDMO Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Peptide CDMO Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Peptide CDMO revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Peptide CDMO revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bachem
PolyPeptide
CordenPharma
AmbioPharm
USV Peptides
Thermofischer
Bio Basic
JPT
Genscript
Xinbang Pharma
ScinoPharm
SN Biopharm
CBL
Piramal Pharma
CPC Scientific
Outline of Major Chapters:
Chapter 1: Introduces the definition of Peptide CDMO, market overview.
Chapter 2: Global Peptide CDMO market size in revenue.
Chapter 3: Detailed analysis of Peptide CDMO company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Peptide CDMO in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Peptide CDMO Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Peptide CDMO Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Peptide CDMO Overall Market Size
2.1 Global Peptide CDMO Market Size: 2022 VS 2029
2.2 Global Peptide CDMO Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Peptide CDMO Players in Global Market
3.2 Top Global Peptide CDMO Companies Ranked by Revenue
3.3 Global Peptide CDMO Revenue by Companies
3.4 Top 3 and Top 5 Peptide CDMO Companies in Global Market, by Revenue in 2022
3.5 Global Companies Peptide CDMO Product Type
3.6 Tier 1, Tier 2 and Tier 3 Peptide CDMO Players in Global Market
3.6.1 List of Global Tier 1 Peptide CDMO Companies
3.6.2 List of Global Tier 2 and Tier 3 Peptide CDMO Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Peptide CDMO Market Size Markets, 2022 & 2029
4.1.2 APIs and Intermediates
4.1.3 FDF
4.2 By Type - Global Peptide CDMO Revenue & Forecasts
4.2.1 By Type - Global Peptide CDMO Revenue, 2018-2023
4.2.2 By Type - Global Peptide CDMO Revenue, 2024-2029
4.2.3 By Type - Global Peptide CDMO Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Peptide CDMO Market Size, 2022 & 2029
5.1.2 Commercial
5.1.3 Academic Research
5.1.4 Other
5.2 By Application - Global Peptide CDMO Revenue & Forecasts
5.2.1 By Application - Global Peptide CDMO Revenue, 2018-2023
5.2.2 By Application - Global Peptide CDMO Revenue, 2024-2029
5.2.3 By Application - Global Peptide CDMO Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Peptide CDMO Market Size, 2022 & 2029
6.2 By Region - Global Peptide CDMO Revenue & Forecasts
6.2.1 By Region - Global Peptide CDMO Revenue, 2018-2023
6.2.2 By Region - Global Peptide CDMO Revenue, 2024-2029
6.2.3 By Region - Global Peptide CDMO Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Peptide CDMO Revenue, 2018-2029
6.3.2 US Peptide CDMO Market Size, 2018-2029
6.3.3 Canada Peptide CDMO Market Size, 2018-2029
6.3.4 Mexico Peptide CDMO Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Peptide CDMO Revenue, 2018-2029
6.4.2 Germany Peptide CDMO Market Size, 2018-2029
6.4.3 France Peptide CDMO Market Size, 2018-2029
6.4.4 U.K. Peptide CDMO Market Size, 2018-2029
6.4.5 Italy Peptide CDMO Market Size, 2018-2029
6.4.6 Russia Peptide CDMO Market Size, 2018-2029
6.4.7 Nordic Countries Peptide CDMO Market Size, 2018-2029
6.4.8 Benelux Peptide CDMO Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Peptide CDMO Revenue, 2018-2029
6.5.2 China Peptide CDMO Market Size, 2018-2029
6.5.3 Japan Peptide CDMO Market Size, 2018-2029
6.5.4 South Korea Peptide CDMO Market Size, 2018-2029
6.5.5 Southeast Asia Peptide CDMO Market Size, 2018-2029
6.5.6 India Peptide CDMO Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Peptide CDMO Revenue, 2018-2029
6.6.2 Brazil Peptide CDMO Market Size, 2018-2029
6.6.3 Argentina Peptide CDMO Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Peptide CDMO Revenue, 2018-2029
6.7.2 Turkey Peptide CDMO Market Size, 2018-2029
6.7.3 Israel Peptide CDMO Market Size, 2018-2029
6.7.4 Saudi Arabia Peptide CDMO Market Size, 2018-2029
6.7.5 UAE Peptide CDMO Market Size, 2018-2029
7 Peptide CDMO Companies Profiles
7.1 Bachem
7.1.1 Bachem Company Summary
7.1.2 Bachem Business Overview
7.1.3 Bachem Peptide CDMO Major Product Offerings
7.1.4 Bachem Peptide CDMO Revenue in Global Market (2018-2023)
7.1.5 Bachem Key News & Latest Developments
7.2 PolyPeptide
7.2.1 PolyPeptide Company Summary
7.2.2 PolyPeptide Business Overview
7.2.3 PolyPeptide Peptide CDMO Major Product Offerings
7.2.4 PolyPeptide Peptide CDMO Revenue in Global Market (2018-2023)
7.2.5 PolyPeptide Key News & Latest Developments
7.3 CordenPharma
7.3.1 CordenPharma Company Summary
7.3.2 CordenPharma Business Overview
7.3.3 CordenPharma Peptide CDMO Major Product Offerings
7.3.4 CordenPharma Peptide CDMO Revenue in Global Market (2018-2023)
7.3.5 CordenPharma Key News & Latest Developments
7.4 AmbioPharm
7.4.1 AmbioPharm Company Summary
7.4.2 AmbioPharm Business Overview
7.4.3 AmbioPharm Peptide CDMO Major Product Offerings
7.4.4 AmbioPharm Peptide CDMO Revenue in Global Market (2018-2023)
7.4.5 AmbioPharm Key News & Latest Developments
7.5 USV Peptides
7.5.1 USV Peptides Company Summary
7.5.2 USV Peptides Business Overview
7.5.3 USV Peptides Peptide CDMO Major Product Offerings
7.5.4 USV Peptides Peptide CDMO Revenue in Global Market (2018-2023)
7.5.5 USV Peptides Key News & Latest Developments
7.6 Thermofischer
7.6.1 Thermofischer Company Summary
7.6.2 Thermofischer Business Overview
7.6.3 Thermofischer Peptide CDMO Major Product Offerings
7.6.4 Thermofischer Peptide CDMO Revenue in Global Market (2018-2023)
7.6.5 Thermofischer Key News & Latest Developments
7.7 Bio Basic
7.7.1 Bio Basic Company Summary
7.7.2 Bio Basic Business Overview
7.7.3 Bio Basic Peptide CDMO Major Product Offerings
7.7.4 Bio Basic Peptide CDMO Revenue in Global Market (2018-2023)
7.7.5 Bio Basic Key News & Latest Developments
7.8 JPT
7.8.1 JPT Company Summary
7.8.2 JPT Business Overview
7.8.3 JPT Peptide CDMO Major Product Offerings
7.8.4 JPT Peptide CDMO Revenue in Global Market (2018-2023)
7.8.5 JPT Key News & Latest Developments
7.9 Genscript
7.9.1 Genscript Company Summary
7.9.2 Genscript Business Overview
7.9.3 Genscript Peptide CDMO Major Product Offerings
7.9.4 Genscript Peptide CDMO Revenue in Global Market (2018-2023)
7.9.5 Genscript Key News & Latest Developments
7.10 Xinbang Pharma
7.10.1 Xinbang Pharma Company Summary
7.10.2 Xinbang Pharma Business Overview
7.10.3 Xinbang Pharma Peptide CDMO Major Product Offerings
7.10.4 Xinbang Pharma Peptide CDMO Revenue in Global Market (2018-2023)
7.10.5 Xinbang Pharma Key News & Latest Developments
7.11 ScinoPharm
7.11.1 ScinoPharm Company Summary
7.11.2 ScinoPharm Business Overview
7.11.3 ScinoPharm Peptide CDMO Major Product Offerings
7.11.4 ScinoPharm Peptide CDMO Revenue in Global Market (2018-2023)
7.11.5 ScinoPharm Key News & Latest Developments
7.12 SN Biopharm
7.12.1 SN Biopharm Company Summary
7.12.2 SN Biopharm Business Overview
7.12.3 SN Biopharm Peptide CDMO Major Product Offerings
7.12.4 SN Biopharm Peptide CDMO Revenue in Global Market (2018-2023)
7.12.5 SN Biopharm Key News & Latest Developments
7.13 CBL
7.13.1 CBL Company Summary
7.13.2 CBL Business Overview
7.13.3 CBL Peptide CDMO Major Product Offerings
7.13.4 CBL Peptide CDMO Revenue in Global Market (2018-2023)
7.13.5 CBL Key News & Latest Developments
7.14 Piramal Pharma
7.14.1 Piramal Pharma Company Summary
7.14.2 Piramal Pharma Business Overview
7.14.3 Piramal Pharma Peptide CDMO Major Product Offerings
7.14.4 Piramal Pharma Peptide CDMO Revenue in Global Market (2018-2023)
7.14.5 Piramal Pharma Key News & Latest Developments
7.15 CPC Scientific
7.15.1 CPC Scientific Company Summary
7.15.2 CPC Scientific Business Overview
7.15.3 CPC Scientific Peptide CDMO Major Product Offerings
7.15.4 CPC Scientific Peptide CDMO Revenue in Global Market (2018-2023)
7.15.5 CPC Scientific Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LED Light-Up Blanket Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 116 |
Pelvic Floor Functional Magnetic Stimulator Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Multi-Modality Biofeedback System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
High Frequency Evaluation and Therapy Device Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
